Skip to content

Paralyzed with the Frustration of Pediatric Sedation

Of the pediatric patients that are admitted to an intensive care unit, more than 40% of these admissions require mechanical ventilation. In the pediatric intensive care unit (PICU), appropriate monitoring and use of agents for sedation and paralysis is vital, especially in patients who require mechanical ventilation. This CE presentation will educate pharmacists on the most up-to-date, evidence-based, guideline-recommended approach to sedation, paralysis, and delirium in the PICU.

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Recognize appropriate agents used for sedation in patients admitted to the PICU.
  • Identify appropriate agents used for paralysis in patients admitted to the PICU based on patient-specific factors.
  • Describe pharmacologic strategies used to avoid or minimize delirium in pediatric patients admitted to the PICU.

Presenter

Hailey Chapdelaine, PharmD, is a PGY1 Pharmacy Resident at Baystate Medical Center in Springfield, MA. Hailey earned her PharmD at the University of Rhode Island in Kingston, RI. Hailey’s practice interests include pediatrics and critical care.

Registration Fee: This module is provided free of charge.


Release Date: June 14, 2022
Expiration Date: June 14, 2023
ACPE UAN: 0026-0000-22-133-H01-P | Knowledge
Topic Designator: Disease State Management/Drug Therapy
Contact Hours:
1 (0. 1 CEU)

Accreditation

ACPE logo

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this activity for a total of 1 contact hour (0.1 CEU).

Requirements for Credit

In order to receive credit, the participant must view the entire presentation and complete the pre and post-tests, and evaluation form. Upon completion, participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Statement of Disclosure

Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.

Hailey Chapdelaine has no relevant financial relationships with ineligible companies to disclose.

Residency Director Frank Szczerba has no relevant financial relationships with ineligible companies to disclose.

Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.

No funding from industry provided for this event. No exhibitors will be present.